| Reactivity | MuSpecies Glossary |
| Applications | Bioactivity |
| Format | Carrier-Free |
| Details of Functionality | Measured by its ability to inhibit IL-2 secretion by mouse T cells in the presence of anti-CD3. The ED50 for this effect is 1-6 μg/mL. |
| Source | Mouse myeloma cell line, NS0-derived mouse BTNL2/Butyrophilin-like 2 protein Asp27-Ser452, with a C-terminal 6-His tag |
| Accession # | |
| N-terminal Sequence | Asp27 |
| Protein/Peptide Type | Recombinant Proteins |
| Gene | Btnl2 |
| Purity | >95%, by SDS-PAGE with silver staining. |
| Purity Statement | Antigen Affinity-purified |
| Endotoxin Note | <0.10 EU per 1 μg of the protein by the LAL method. |
| Dilutions |
|
| Theoretical MW | 49 kDa. Disclaimer note: The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors. |
| SDS-PAGE | 54-67 kDa, reducing conditions |
| Storage | Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
|
| Buffer | Lyophilized from a 0.2 μm filtered solution in PBS. |
| Purity | >95%, by SDS-PAGE with silver staining. |
| Reconstitution Instructions | Reconstitute at 200 μg/mL in PBS. |
Butyrophilin-like 2 (BTNL2) is a member of the BTN/MOG Ig-superfamily and functions as a negative regulator of immune cell activation (1).Mouse BTNL2 is a 514 amino acid (aa) type I transmembrane glycoprotein that contains a signal peptide followed by an extracellular domain (ECD), a transmembrane region and a short cytoplasmic domain (2). The ECD features two V-type Ig-like domains, two C-type Ig-like domains, and four glycosylation sites. The ECD of mouse BTNL2 (aa 27-452) shares 64% and 88% sequence identity with the ECD of human and rat BTNL2, respectively. A splice variant of BTNL2 lacks the second Ig-like domain in the ECD (2). BTNL2 is expressed in epithelial cells of the small intestine, colonic dendritic cells, and in cells of the lymph node (1, 2). BTNL2 expression is upregulated in T cells following activation, a characteristic BTNL2 shares with the homologous B7 family of co-stimulatory molecules (3, 4). BTNL2 negatively regulates T cells by inhibiting proliferation and inflammatory cytokine secretion (1, 3). It also increases the expression of FoxP3 in T cells to promote regulatory T cell development (5). Single nucleotide polymorphisms in BTNL2 are associated with a risk for sporadic prostate cancer, rheumatoid arthritis, sarcoidosis, ulcerative colitis, and other inflammatory diseases (2, 6-12).
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.